ID Name Structure References (top 5) Molecular Target(s)
1ID:168
AJMALICINE


NSC#:72115
NSC#:72133
NSC#:72291
NSC#:95087
Aldrich#:446475
Aldrich#:R289094

Freqency:
in 2 ingredients:

  • 55
  • 937

  • Properties
    C21H24N2O3    352.43





    1:  Gherardi R, Louarn F, Benvenuti C, Perrier M, Lejonc JL, Schaeffer A, Degos JD.
    Peripheral neuropathy in patients treated with almitrine dimesylate.
    Lancet.    impact factor:   10.197
    1985;  1(8440): 1247-50

    2:  Mizukami H, Nordlov H, Lee SL, Scott AI.
    Purification and properties of strictosidine synthetase (an enzyme condensing tryptamine and secologanin) from Catharanthus roseus cultured cells.
    Biochemistry.    impact factor:   4.493
    1979;  18(17): 3760-3

    3:  Strobl GR, von Kruedener S, Stockigt J, Guengerich FP, Wolff T.
    Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies.
    J Med Chem.    impact factor:   4.079
    1993;  36(9): 1136-45

    4:  Demichel P, Roquebert J.
    Effects of raubasine stereoisomers on pre- and postsynaptic alpha-adrenoceptors in the rat vas deferens.
    Br J Pharmacol.    impact factor:   3.722
    1984;  83(2): 505-10

    5:  Demichel P, Gomond P, Roquebert J.
    alpha-Adrenoceptor blocking properties of raubasine in pithed rats.
    Br J Pharmacol.    impact factor:   3.722
    1982;  77(3): 449-54

    GFAP
    LC
    P450
    S-100
    STEP
    YES
     
    Time used: 125 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005